Corticosteroids for COVID-19
Coronavirus disease 19 (COVID-19) is placing a major burden on healthcare, economy and social systems worldwide owing to its fast spread and unacceptably high death toll. The unprecedented research effort has established the role of a deregulated immune response to the severe acute respiratory syndr...
Main Author: | Djillali Annane |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-07-01
|
Series: | Journal of Intensive Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667100X21000037 |
Similar Items
-
Systemic Corticosteroids in COVID-19: Critical Appraisal of the WHO Meta-analysis
by: Sérgio Renato da Rosa Decker, et al.
Published: (2021-03-01) -
Bacterial biogram in COVID-19 patients in Menoufia University isolation hospitals
by: Gehan A Abdelaal, et al.
Published: (2022-01-01) -
Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia
by: Miguel Alejandro Pinzón, et al.
Published: (2021-09-01) -
Corticosteroids in COVID-19: pros and cons
by: Aymen Bahsoun, et al.
Published: (2023-08-01) -
Distribution of Pathogens and Predictive Values of Biomarkers of Inflammatory Response at ICU Admission on Outcomes of Critically Ill COVID-19 Patients with Bacterial Superinfections—Observations from National COVID-19 Hospital in Croatia
by: Maja Ćurčić, et al.
Published: (2022-08-01)